MEN-2

(redirected from Multiple endocrine neoplasia type 2)
Also found in: Medical, Wikipedia.
AcronymDefinition
MEN-2Multiple Endocrine Neoplasia Type 2
References in periodicals archive ?
The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype.
Multiple endocrine neoplasia type 2 RET protooncogene database: repository of MEN2-associated RET sequence variation and reference for genotype/phenotype correlations.
Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes.
Pyrosequencing technology as a method for the diagnosis of multiple endocrine neoplasia type 2.
A report of a granular cell pituicytoma associated with multiple endocrine neoplasia type 2 is in the literature[10]; however, this tumor is an example of a granular cell tumor or granular cell myoblastoma.
Multiple endocrine neoplasia type 2 (MEN2) is an autosomal dominant cancer syndrome that can be divided into three clinical subtypes: MEN2A, MEN2B, and familial medullary thyroid carcinoma (MTC).
Moreover, germline RET mutations are associated with the three variants of the inherited cancer syndrome, multiple endocrine neoplasia type 2 (MEN2A, MEN213, and FMTC).
Full browser ?